Showing 1421-1430 of 2150 results for "".
- Refractive Surgery Council Reports 48% YTD Increase in Laser Vision Correction Procedure Volume Over 2020https://modernod.com/news/refractive-surgery-council-reports-48-ytd-increase-in-laser-vision-correction-procedure-volume-over-2020/2480407/T
- Report: Diagnosed Cases of AMD in the Seven Major Markets Expected to Grow Over Next 10 Yearshttps://modernod.com/news/report-diagnosed-cases-of-amd-in-the-seven-major-markets-expected-to-grow-over-next-10-years/2480979/Diagnosed prevalent cases of age-related macular degeneration (AMD) in the seven major markets combined is expected to increase from 33.66 million cases in 2021 to 40.32 million in 2031, at an annual growth rate (AGR) of 1.98%, according to GlobalData. Of the seven major mark
- FYidoctors Makes Expansion into US Markethttps://modernod.com/news/fyidoctors-makes-expansion-into-us-market/2480296/Canadian eye care provider FYidoctors announced that it has expanded its geographic operations into the US marketplace with the addition of six leading eye care clinics throughout the state of California. The foray marks a major company milestone as the first time FYidoctors has ad
- Market Scope: US Cataract Pharmaceuticals Evolve in Drug Deliveryhttps://modernod.com/news/market-scope-us-cataract-pharmaceuticals-evolve-in-drug-delivery/2479107/US cataract surgeons showed a preference for incremental improvement in drug delivery over revolutionary change in the first full year for three new corticosteroid products to manage inflammation and pain after cataract surgery, according to a Market Scope report. The products hit the mark
- Staar Surgical Gains Supplemental Lens Approval for EVO Visian ICL to Target Post-Cataract Market Opportunityhttps://modernod.com/news/staar-surgical-gains-supplemental-lens-approval-for-evo-visian-icl-to-target-post-cataract-market-opportunity/2477226/Staar Surgical announced it has gained CE Mark approval for use of its ICL as a supplemental or “piggyback” lens in post-cataract IOL surgery patients (pseudophakics). A supplemental EVO ICL is placed in front of the cataract IOL lens in post-cataract patients, just like the EVO ICL is placed in
- International Sports Vision Association Announces Leadership Appointments OF NEW EXECUTIVE AND ADVISORY BOARD OFFICERShttps://modernod.com/news/international-sports-vision-association-announces-leadership-appointments-of-new-executive-and-advisory-board-officers/2481491/The International Sports Vision Association (ISVA) announced the appointments of its new Executive and Advisory Board members, effective April 1, 2023. Executive Board Alireza Somji, OD assumes the position of President, succeeding Charles Shidlofsky, OD, FCOV
- Neuro-Optometric Rehabilitation Association Announces Appointments of New Executive and Advisory Board Officershttps://modernod.com/news/neuro-optometric-rehabilitation-association-announces-appointments-of-new-executive-and-advisory-board-officers/2478297/The Neuro-Optometric Rehabilitation Association (NORA) announced the appointments of its new executive and advisory board members. DeAnn Fitzgerald, OD, assumes the position of President, succeeding Susan Daniel, OD, who now joins the NORA Advisory Board. Dr. Fitzgerald has been providing
- Erin Powers Joins J&J Vision as Vice President of US Sales and Marketing for its Surgical Vision Portfoliohttps://modernod.com/news/erin-powers-joins-jj-vision-as-vice-president-of-us-sales-and-marketing-for-its-surgical-vision-portfolio/2481838/Johnson & Johnson announced the appointment of Erin Powers to the position of Vice President of US Sales and Marketing for its Surgical Vision portfolio. Ms. Powers will lead the US sales, marketing, and professional education teams, and will join the company within t
- Market Scope: Improved Vitrectomy Machine Features Expected to Expand Retinal Treatmentshttps://modernod.com/news/market-scope-improved-vitrectomy-machine-features-expected-to-expand-retinal-treatments/2481617/Advancements in vitrectomy machine technology are expected to improve safety and efficacy and enable surgeons to reach a larger population of patients with retinal disease over the next 5 years, according to a Market Scope report. These advancements include small-incision vitrectomy, subretinal t
- NovaSight Announces Commercial Release of CureSight in the US; Names a New VP of Sales & Marketinghttps://modernod.com/news/novasight-introduces-curesight-to-the-us-and-names-a-new-vp-of-sales-marketing/2481295/NovaSight has announced that its CureSight digital therapy for amblyopia will be released to the US market beginning this month. CureSight received FDA 510(K) clearance based on a pivotal study that found the device to be noninferior to eye patching—t